The Anti-Sm test detects the presence of antibodies against Smith (Sm) antigens, which are specific to systemic lupus erythematosus (SLE). These antibodies are highly specific for SLE and are included in the classification criteria for the disease.

The Anti-Sm test involves a blood draw, which is generally safe with minimal risks such as minor pain, bruising, or, rarely, infection at the puncture site.

The Anti-Sm test results are typically reported as positive or negative. Specific reference ranges may vary among laboratories, but a positive result indicates the presence of anti-Smith antibodies.

Positive result: Presence of anti-Smith antibodies indicates a high specificity for SLE. However, not all individuals with SLE have detectable anti-Sm antibodies, and their absence does not rule out the diagnosis. Negative result: Absence of anti-Smith antibodies does not exclude the diagnosis of SLE, as there are other autoantibodies and clinical features associated with the disease.

The Anti-Sm test requires a blood sample, typically collected from a vein in the arm using a needle. Serum or plasma is separated from the blood cells and then tested for the presence of anti-Smith antibodies using various laboratory methods, such as enzyme-linked immunosorbent assay (ELISA) or immunoblotting.